UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

NAFLD: A multisystem disease

Journal of hepatology, 2015-04, Vol.62 (1), p.S47-S64

2015

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

Journal of hepatology, 2016-09, Vol.65 (3), p.589-600

2016

Volltextzugriff (PDF)

Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action

Molecular aspects of medicine, 2018-12, Vol.64, p.135-146

2018

Volltextzugriff (PDF)

Complications, morbidity and mortality of nonalcoholic fatty liver disease

Metabolism, clinical and experimental, 2020-10, Vol.111, p.154170-154170, Article 154170

2020

Volltextzugriff (PDF)

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies

Nutrition, metabolism, and cardiovascular diseases, 2020-07, Vol.30 (8), p.1236-1248

2020

Volltextzugriff (PDF)

NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment

Diabetes & metabolism, 2021-03, Vol.47 (2), p.101215-101215, Article 101215

2021

Volltextzugriff (PDF)

Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis

Metabolism, clinical and experimental, 2018-02, Vol.79, p.64-76

2018

Volltextzugriff (PDF)

Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease

Journal of hepatology, 2023-01, Vol.78 (1), p.191-206

2023

Volltextzugriff (PDF)

Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week

Journal of the American College of Cardiology, 2022-01, Vol.79 (2), p.180-191

2022

Volltextzugriff (PDF)

CKD and Nonalcoholic Fatty Liver Disease

American journal of kidney diseases, 2014-10, Vol.64 (4), p.638-652

2014

Volltextzugriff (PDF)

Current status and future trends of the global burden of MASLD

Trends in endocrinology and metabolism, 2024-08, Vol.35 (8), p.697-707

2024

Volltextzugriff (PDF)

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

Digestive and liver disease, 2015-12, Vol.47 (12), p.997-1006

2015

Volltextzugriff (PDF)

Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis

Metabolism, clinical and experimental, 2018-10, Vol.87, p.1-12

2018

Volltextzugriff (PDF)

Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents

Journal of hepatology, 2017-05, Vol.66 (5), p.1031-1036

2017

Volltextzugriff (PDF)

MAFLD and risk of CKD

Metabolism, clinical and experimental, 2021-02, Vol.115, p.154433-154433, Article 154433

2021

Volltextzugriff (PDF)

Reply to Dr. Chiang's comments

Diabetes & metabolism, 2023-05, Vol.49 (3), p.101445-101445, Article 101445

2023

Volltextzugriff (PDF)

Steatotic liver disease, MASLD and risk of chronic kidney disease

Diabetes & metabolism, 2024-01, Vol.50 (1), p.101506-101506, Article 101506

2024

Volltextzugriff (PDF)

Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver

Journal of hepatology, 2016-10, Vol.65 (4), p.791-797

2016

Volltextzugriff (PDF)

Fatty liver: Role of inflammation and fatty acid nutrition

Prostaglandins, leukotrienes and essential fatty acids, 2010-04, Vol.82 (4), p.265-271

Byrne, Christopher D

2010

Volltextzugriff (PDF)

Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension

Journal of hepatology, 2014-05, Vol.60 (5), p.1040-1045

2014

Volltextzugriff (PDF)

Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2016, Vol.150 (1), p.7-10

2016

Volltextzugriff (PDF)

Why are there no strategies for NAFLD?

Journal of hepatology, 2022-04, Vol.76 (4), p.763-764

2022

Volltextzugriff (PDF)

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.1597-1610.e7

2020

Volltextzugriff (PDF)

Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver

Atherosclerosis, 2018-08, Vol.275, p.50-57

2018

Volltextzugriff (PDF)

Redefining the golden hour for severe head injury in an urban setting: The effect of prehospital arrival times on patient outcomes

Injury, 2013-05, Vol.44 (5), p.606-610

2013

Volltextzugriff (PDF)

1 – 25 von 271

Suche als RSS-Feed

Aktive Filter

ThemaLiver Diseases

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(269)
Mit Volltextzugriff
(264)

Publikationsform

Artikel
(269)
Tagungsberichte
(2)

Sprache

Englisch
(271)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

NAFLD: A multisystem disease

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action

Complications, morbidity and mortality of nonalcoholic fatty liver disease

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies

NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment

Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis

Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease

Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week

CKD and Nonalcoholic Fatty Liver Disease

Current status and future trends of the global burden of MASLD

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis

Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents

MAFLD and risk of CKD

Reply to Dr. Chiang's comments

Steatotic liver disease, MASLD and risk of chronic kidney disease

Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver

Fatty liver: Role of inflammation and fatty acid nutrition

Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension

Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease

Why are there no strategies for NAFLD?

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease

Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver

Redefining the golden hour for severe head injury in an urban setting: The effect of prehospital arrival times on patient outcomes

Aktive Filter

Suchergebnisse filtern